Dietary flavonoids and nitrate: Effects on nitric oxide and vascular function

Nutrition Reviews

Volumn 73, Issue 4, 2015, Pages 216-235

  Bondonno, Catherine P ^a   Croft, Kevin D ^a   Ward, Natalie ^a   Considine, Michael J ^b,c   Hodgson, Jonathan M ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c DEPARTMENT OF AGRICULTURE AND FOOD WESTERN AUSTRALIA   (Australia)

Author keywords

Flavonoids, nitrate; Nitric oxide; Vascular function

Indexed keywords

ARGININE; EPICATECHIN; FLAVANONE DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOID GLYCOSIDE; FLAVONOL DERIVATIVE; ISOFLAVONE DERIVATIVE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PHENOL DERIVATIVE; POLYPHENOL; QUERCETIN; NITRIC ACID DERIVATIVE; PLANT EXTRACT;

ADRENERGIC SYSTEM; ARTERIAL STIFFNESS; ARTICLE; BIOAVAILABILITY; BLOOD VESSEL FUNCTION; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DIETARY INTAKE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; EPIDEMIOLOGICAL DATA; EVIDENCE BASED PRACTICE; FRUIT; GASTROINTESTINAL ABSORPTION; HEART PROTECTION; HUMAN; HYPERTENSION; METABOLISM PARAMETERS; MOLECULAR BIOLOGY; NONHUMAN; POPULATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE FUNCTION; TOXICITY TESTING; VEGETABLE; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CHEMISTRY; DIET; DRUG EFFECTS; METABOLISM; PHYTOTHERAPY;

CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DIET; FLAVONOIDS; FRUIT; HUMANS; NITRATES; NITRIC OXIDE; PHYTOTHERAPY; PLANT EXTRACTS; VEGETABLES;

EID: 84938694307     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1093/nutrit/nuu014     Document Type: Article

References (225)

1. Mendis S, Puska P, Norrving B. Global Atlas on Cardiovascular Disease Prevention and Control. Geneva, Switzerland: World Health Organization; 2011.
2. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336:1117-1124.
3. Joshipura KJ, Ascherio A, Manson JE, et al. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA. 1999;282:1233-1239.
4. Joshipura KJ, Hu FB, Manson JE, et al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med. 2001;134:1106-1114.
5. Widlansky ME, Gokce N, Keaney JF Jr, et al. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149-1160.
6. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol. 2004;15: 1983-1992.
7. Vanhoutte PM. Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ J. 2009;73:595-601.
8. Herrmann J, Lerman A. The endothelium-the cardiovascular health barometer. Herz. 2008;33:343-353.
9. Yeboah J, Crouse JR, Hsu F-C, et al. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation. 2007;115:2390-2397.
10. Giansante C, Fiotti N. Insights into human hypertension: the role of endothelial dysfunction. J Hum Hypertens. 2006;20:725-726.
11. Yang Z, Ming X-F. Recent advances in understanding endothelial dysfunction in atherosclerosis. Clin Med Res. 2006;4:53-65.
12. Cosentino F, Volpe M. Hypertension, stroke, and endothelium. Curr Hypertens Rep. 2005;7:68-71.
13. Vita JA, Keaney JF Jr. Endothelial function. A barometer for cardiovascular risk? Circulation. 2002;106:640-642.
14. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357(Pt 3):593-615.
15. Bredt DS. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res. 1999;31:577-596.
16. Bredt DS. Nitric oxide signaling specificity-the heart of the problem. J Cell Sci. 2003;116:9-15.
17. Jin RC, Loscalzo J. Vascular nitric oxide: formation and function. J Blood Med. 2010;1:147-162.
18. Liu VWT, Huang PL. Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice. Cardiovasc Res. 2008;77:19-29.
19. Marletta MA. Nitric oxide synthase: aspects concerning structure and catalysis. Cell. 1994;78:927-930.
20. Munzel T, Daiber A, Ullrich V, et al. Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase. Arterioscler Thromb Vasc Biol. 2005;25:1551-1557.
21. Liu X, Miller MJS, Joshi MS, et al. Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem. 1998;273:18709-18713.
22. Beckman JS. Understanding peroxynitrite biochemistry and its potential for treating human diseases. Arch Biochem Biophys. 2009;484:114-116.
23. MacArthur PH, Shiva S, Gladwin MT. Measurement of circulating nitrite and S-nitrosothiols by reductive chemiluminescence. J Chromatogr B. 2007;851: 93-105.
24. Barbotin-Larrieu F, Mazmanian M, Baudet B, et al. Prevention of ischemia-reperfusion lung injury by inhaled nitric oxide in neonatal piglets. J Appl Physiol. 1996;80:782-788.
25. Cannon RO, Schechter AN, Panza JA, et al. Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest. 2001;108:279-288.
26. Fox-Robichaud A, Payne D, Hasan SU, et al. Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest. 1998;101:2497-2505.
27. Takahashi Y, Kobayashi H, Tanaka N, et al. Nitrosyl hemoglobin in blood of normoxic and hypoxic sheep during nitric oxide inhalation. Am J Physiol Heart Circ Physiol. 1998;274:H349-H357.
28. Troncy E, Francoeur M, Salazkin I, et al. Extra-pulmonary effects of inhaled nitric oxide in swine with and without phenylephrine. Brit J Anaesth. 1997;79:631-640.
29. Rassaf T, Kleinbongard P, Preik M, et al. Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO: experimental and clinical study on the fate of NO in human blood. Circ Res. 2002;91:470-477.
30. Govoni M, Jansson EA, Weitzberg E, et al. The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash. Nitric Oxide. 2008;19:333-337.
31. Petersson J, Carlström M, Schreiber O, et al. Gastroprotective and blood pressure lowering effects of dietary nitrate are abolished by an antiseptic mouthwash. Free Radic Biol Med. 2009;46:1068-1075.
32. Webb AJ, Patel N, Loukogeorgakis S, et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension. 2008;51:784-790.
33. Spiegelhalder B, Eisenbrand G, Preussmann R. Influence of dietary nitrate on nitrite content of human saliva: possible relevance to in vivo formation of N-nitroso compounds. Food Cosmet Toxicol. 1976;14:545-548.
34. Gladwin MT, Schechter AN, Kim-Shapiro DB, et al. The emerging biology of the nitrite anion. Nat Chem Biol. 2005;1:308-314.
35. Bjorne HH, Petersson J, Phillipson M, et al. Nitrite in saliva increases gastric mucosal blood flow and mucus thickness. J Clin Invest. 2004;113:106-114.
36. Dykhuizen RS, Frazer R, Duncan C, et al. Antimicrobial effect of acidified nitrite on gut pathogens: importance of dietary nitrate in host defense. Antimicrob Agents Chemother. 1996;40:1422-1425.
37. Petersson J, Phillipson M, Jansson EA, et al. Dietary nitrate increases gastric mucosal blood flow and mucosal defense. Am J Physiol Gastrointest Liver Physiol. 2007;292:G718-G724.
38. Lundberg JO, Govoni M. Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic Biol Med. 2004;37:395-400.
39. Larsen FJ, Ekblom B, Sahlin K, et al. Effects of dietary nitrate on blood pressure in healthy volunteers. N Engl J Med. 2006;355:2792-2793.
40. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. The Lancet. 1989;334:997-1000.
41. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci U S A. 1989;86:3375-3378.
42. Haynes WG, Noon JP, Walker BR, et al. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens. 1993;11:1375-1380.
43. Stamler JS, Loh E, Roddy M-A, et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation. 1994;89:2035-2040.
44. Stewart AD, Millasseau SC, Kearney MT, et al. Effects of inhibition of basal nitric oxide synthesis on carotid-femoral pulse wave velocity and augmentation index in humans. Hypertension. 2003;42:915-918.
45. Vallance P, Chan N. Endothelial function and nitric oxide: clinical relevance. Heart. 2001;85:342-350.
46. Cayatte AJ, Palacino JJ, Horten K, et al. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol. 1994;14:753-759.
47. Bazzano LA, Serdula MK, Liu S. Dietary intake of fruits and vegetables and risk of cardiovascular disease. Curr Atheroscler Rep. 2003;5:492-499.
48. Ness AR, Powles JW. Fruit and vegetables, and cardiovascular disease: a review. Int J Epidemiol. 1997;26:1-13.
49. van't Veer P, Jansen MC, Klerk M, et al. Fruits and vegetables in the prevention of cancer and cardiovascular disease. Public Health Nutr. 2000;3:103-107.
50. Bjelakovic G, Nikolova D, Gluud LL, et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention. JAMA. 2007;297: 842-857.
51. Vivekananthan DP, Penn MS, Sapp SK, et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. The Lancet. 2003;361:2017-2023.
52. Beecher GR. Overview of dietary flavonoids: nomenclature, occurrence and intake. J Nutr. 2003;133:3248S-3254S.
53. Manach C, Williamson G, Morand C, et al. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005; 81:230S-242S.
54. Hollman PCH, Katan MB. Absorption, metabolism and health effects of dietary flavonoids in man. Biomed Pharmacother. 1997;51:305-310.
55. Harborne JB, Baxter H. The Handbook of Natural Flavonoids. Volume 1 and Volume 2. New York: John Wiley & Sons; 1999.
56. Manach C, Scalbert A, Morand C, et al. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004;79:727-747.
57. Geleijnse JM, Hollman P. Flavonoids and cardiovascular health: which compounds, what mechanisms? Am J Clin Nutr. 2008;88:12-13.
58. Erdman JW Jr, Balentine D, Arab L, et al. Flavonoids and heart health: proceedings of the ILSI North America flavonoids workshop, May 31-June 1, 2005, Washington, DC. J Nutr. 2007;137(Suppl):718S-737S.
59. Hooper L, Kroon PA, Rimm EB, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88:38-50.
60. Nemeth K, Plumb GW, Berrin JG, et al. Deglycosylation by small intestinal epithelial cell beta-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. Eur J Nutr. 2003;42:29-42.
61. Day AJ, Diaz JC, Kroon PA, et al. Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett. 2000;468: 166-170.
62. Gee JM, DuPont MS, Day AJ, et al. Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. J Nutr. 2000;130:2765-2771.
63. Kottra G, Daniel H. Flavonoid glycosides are not transported by the human Na+/ glucose transporter when expressed in Xenopus laevis oocytes, but effectively inhibit electrogenic glucose uptake. J Pharmacol Exp Ther. 2007;322:829-835.
64. Donovan JL, Manach C, Faulks RM, et al. Absorption and metabolism of dietary plant secondary metabolites. in Crozier A, Clifford MN, Ashira H, (eds) Plant Secondary Metabolites. 2006, Blackwell Publishing, Oxford, UK, 303-351.
65. Graefe EU, Wittig J, Mueller S, et al. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol. 2001;41:492-499.
66. Hollman PCH, Bijsman MNCP, van Gameren Y, et al. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic Res. 1999;31:569-573.
67. Ottaviani JI, Momma TY, Heiss C, et al. The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo. Free Radic Biol Med. 2011;50:237-244.
68. Appeldoorn MM, Vincken J-P, Gruppen H, et al. Procyanidin dimers A1, A2, and B2 are absorbed without conjugation or methylation from the small intestine of rats. J Nutr. 2009;139:1469-1473.
69. Selma MV, Espilin JC, Tomas-Barberan FA. Interaction between phenolics and gut microbiota: role in human health. J Agric Food Chem. 2009;57: 6485-6501.
70. Radominska-Pandya A, Little JM, Pandya JT, et al. UDP-glucuronosyltransferases in human intestinal mucosa. Biochim Biophys Acta. 1998;1394:199-208.
71. O'Leary KA, Day AJ, Needs PW, et al. Metabolism of quercetin-7-and quercetin-3- glucuronides by an in vitro hepatic model: the role of human [beta]-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol. 2003;65:479-491.
72. Aura AM. Microbial metabolism of dietary phenolic compounds in the colon. Phytochem Rev. 2008;7:407-429.
73. Lila MA, Raskin I. Health-related interactions of phytochemicals. J Food Sci. 2005; 70:R20-R27.
74. Lampe JW, Chang JL. Interindividual differences in phytochemical metabolism and disposition. Semin Cancer Biol. 2007;17:347-353.
75. Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr. 2000;130:2073S-2085S.
76. Manach C, Hubert J, Llorach R, et al. The complex links between dietary phytochemicals and human health deciphered by metabolomics. Mol Nutr Food Res. 2009;53:1303-1315.
77. Arts ICW, Hollman PCH. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr. 2005;81(Suppl):317S-325S.
78. McCullough ML, Peterson JJ, Patel R, et al. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr. 2012;95: 454-464.
79. Mink PJ, Scrafford CG, Barraj LM, et al. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr. 2007;85:895-909.
80. Mursu J, Voutilainen S, Nurmi T, et al. Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr. 2008;100:890-895.
81. Ivey KL, Lewis JR, Prince RL, et al. Tea and non-tea flavonol intakes in relation to atherosclerotic vascular disease mortality in older women. Br J Nutr. 2013;110: 1648-1655.
82. Peterson JJ, Dwyer JT, Jacques PF, et al. Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations. Nutr Rev. 2012;70:491-508.
83. Huxley RR, Neil HAW. The relation between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2003;57:904-908.
84. Hollman PCH, Geelen A, Kromhout D. Dietary flavonol intake may lower stroke risk in men and women. J Nutr. 2009;140:600-604.
85. Khawaja O, Gaziano JM, Djousse L. Chocolate and coronary heart disease: a systematic review. Curr Atheroscler Rep. 2011;13:1-6.
86. Lewis JR, Prince RL, Zhu K, et al. Habitual chocolate intake and vascular disease: a prospective study of clinical outcomes in older women. Arch Intern Med. 2010; 170:1857-1858.
87. Knekt P, Jarvinen R, Reunanen A, et al. Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ. 1996;312:478-481.
88. Peters U, Poole C, Arab L. Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol. 2001;154:495-503.
89. Wang ZM, Zhou B, Wang YS, et al. Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr. 2011;93:506-515.
90. Arab L, Liu W, Elashoff D. Green and black tea consumption and risk of stroke. Stroke. 2009;40:1786-1792.
91. Buitrago-Lopez A, Sanderson J, Johnson L, et al. Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ. 2011;343:d4488.
92. Neveu V, Perez-Jimenez J, Vos F, et al. Phenol-explorer: an online comprehensive database on polyphenol contents in foods. Database. 2010.
93. Geleijnse JM, Launer LJ, van der Kuip DAM, et al. Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr. 2002;75:880-886.
94. Hertog MGL, Feskens EJM, Kromhout D, et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. The Lancet. 1993;342: 1007-1011.
95. Zamora-Ros R, Rabassa M, Llorach R, et al. Application of dietary polyphenol biomarkers in epidemiology: past, present and future. J Agric Food Chem. 2012;60: 6648-6657.
96. Mancia G, De Backer G, Dominiczak A, et al. ESH-ESC Practice guidelines for the management of arterial hypertension: ESH-ESC task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1751-1762.
97. Hooper L, Kay C, Abdelhamid A, et al. Effects of chocolate, cocoa, and flavan-3- ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr. 2012;95:740-751.
98. Ried K, Sullivan TR, Fakler P, et al. Effect of cocoa on blood pressure. Cochrane Database Syst Rev. 2012;8 Art. No.: CD008893
99. Liu XX, Li SH, Chen JZ, et al. Effect of soy isoflavones on blood pressure: a metaanalysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2012;22: 463-470.
100. Feringa HHH, Laskey DA, Dickson JE, et al. The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials. J Am Diet Assoc. 2011;111:1173-1181.
101. Aviram M, Dornfeld L. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis. 2001;158:195-198.
102. Aviram M, Rosenblat M, Gaitini D, et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intimamedia thickness, blood pressure and LDL oxidation. Clin Nutr. 2004;23:423-433.
103. Zilkens RR, Burke V, Hodgson JM, et al. Red wine and beer elevate blood pressure in normotensive men. Hypertension. 2005;45:874-879.
104. Barona J, Aristizabal JC, Blesso CN, et al. Grape polyphenols reduce blood pressure and increase flow-mediated vasodilation in men with metabolic syndrome. J Nutr. 2012;142:1626-1632.
105. Park YK, Kim JS, Kang MH. Concord grape juice supplementation reduces blood pressure in Korean hypertensive men: double-blind, placebo controlled intervention trial. Biofactors. 2004;22:145-147.
106. Naruszewicz M, Laniewska I, Millo B, et al. Combination therapy of statin with flavonoids rich extract from chokeberry fruits enhanced reduction in cardiovascular risk markers in patients after myocardial infraction (MI). Atherosclerosis. 2007; 194:e179-e184.
107. Ellinger S, Reusch A, Stehle P, et al. Epicatechin ingested via cocoa products reduces blood pressure in humans: a nonlinear regression model with a Bayesian approach. Am J Clin Nutr. 2012;95:1365-1377.
108. Brown AL, Lane J, Coverly J, et al. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr. 2009;101: 886-894.
109. Edwards RL, Lyon T, Litwin SE, et al. Quercetin reduces blood pressure in hypertensive subjects. J Nutr. 2007;137:2405-2411.
110. Egert S, Bosy-Westphal A, Seiberl J, et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr. 2010;102:1065-1074.
111. Larson A, Witman MAH, Guo Y, et al. Acute, quercetin-induced reductions in blood pressure in hypertensive individuals are not secondary to lower plasma angiotensin-converting enzyme activity or endothelin-1: nitric oxide. Nutr Res. 2012;32:557-564.
112. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. The Lancet. 2003;362:1527-1535.
113. Ras RT, Streppel MT, Draijer R, et al. Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis. Int J Cardiol. 2013;168: 344-351.
114. Ras RT, Zock PL, Draijer R. Tea consumption enhances endothelial-dependent vasodilation: a meta-analysis. PloS ONE. 2011;6:e16974.
115. Beavers DP, Beavers KM, Miller M, et al. Exposure to isoflavone-containing soy products and endothelial function: a Bayesian meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis. 2012;22:182-191.
116. Bondonno CP, Yang X, Croft KD, et al. Flavonoid-rich apples and nitrate-rich spinach augment nitric oxide status and improve endothelial function in healthy men and women: a randomized controlled trial. Free Radic Biol Med. 2012;52: 95-102.
117. Stein JH, Keevil JG, Wiebe DA, et al. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation. 1999;100:1050-1055.
118. Wiebe DA, Folts JD, Stein JH. Effect of ingestion of purple grape juice on endothelial function in patients with coronary heart disease. Am J Cardiol. 2001;88: 553-555.
119. Agewall S, Wright S, Doughty RN, et al. Does a glass of red wine improve endothelial function? Eur Heart J. 2000;21:74-78.
120. Matsumoto H, Takenami E, Iwasaki-Kurashige K, et al. Effects of blackcurrant anthocyanin intake on peripheral muscle circulation during typing work in humans. Eur J Appl Physiol. 2005;94:36-45.
121. Buscemi S, Rosafio G, Arcoleo G, et al. Effects of red orange juice intake on endothelial function and inflammatory markers in adult subjects with increased cardiovascular risk. Am J Clin Nutr. 2012;95:1089-1095.
122. Schroeter H, Heiss C, Balzer J, et al. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A. 2006;103:1024-1029.
123. Ostertag LM, O'Kennedy N, Kroon PA, et al. Impact of dietary polyphenols on human platelet function. A critical review of controlled dietary intervention studies. Mol Nutr Food Res. 2010;54:60-81.
124. Heptinstall S, May J, Fox S, et al. Cocoa flavanols and platelet and leukocyte function: recent in vitro and ex vivo studies in healthy adults. J Cardiovasc Pharmacol. 2006;47:S197-S205.
125. Duffy SJ, Vita JA, Holbrook M, et al. Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2001;21:1084-1089.
126. Hodgson JM, Puddey IB, Mori TA, et al. Effects of regular ingestion of black tea on haemostasis and cell adhesion molecules in humans. Eur J Clin Nutr. 2001;55: 881-886.
127. Lee W, Min WK, Chun S, et al. Long-term effects of green tea ingestion on atherosclerotic biological markers in smokers. Clin Biochem. 2005;38:84-87.
128. Steptoe A, Gibson EL, Vuononvirta R, et al. The effects of chronic tea intake on platelet activation and inflammation: a double-blind placebo controlled trial. Atherosclerosis. 2007;193:277-282.
129. Albers AR, Varghese S, Vitseva O, et al. The antiinflammatory effects of purple grape juice consumption in subjects with stable coronary artery disease. Arterioscler Thromb Vasc Biol. 2004;24:e179-e180.
130. Erlund I, Koli R, Alfthan G, et al. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr. 2008;87: 323-331.
131. Freedman JE, Parker Iii C, Li L, et al. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation. 2001;103:2792-2798.
132. Pace-Asciak CR, Rounova O, Hahn SE, et al. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta. 1996;246: 163-182.
133. Eccleston C, Baoru Y, Tahvonen R, et al. Effects of an antioxidant-rich juice (sea buckthorn) on risk factors for coronary heart disease in humans. J Nutr Biochem. 2002;13:346-354.
134. Vita JA. Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr. 2005;81:292S-297S.
135. Fraga CG, Galleano M, Verstraeten SV, et al. Basic biochemical mechanisms behind the health benefits of polyphenols. Mol Aspects Med. 2010;31:435-445.
136. Actis-Goretta L, Ottaviani JI, Fraga CG. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem. 2006;54:229-234.
137. Balzer J, Rassaf T, Heiss C, et al. Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients: a double-masked, randomized, controlled trial. J Am Coll Cardiol. 2008;51:2141-2149.
138. Gryglewski RJ, Korbut R, Robak J. On the mechanism of antithrombotic action of flavonoids. Biochem Pharmacol. 1987;36:317-322.
139. Heiss C, Dejam A, Kleinbongard P, et al. Vascular effects of cocoa rich in flavan-3- ols. JAMA. 2003;290:1030-1031.
140. Loke WM, Hodgson JM, Proudfoot JM, et al. Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am J Clin Nutr. 2008;88:1018-1025.
141. McCarty MF. Scavenging of peroxynitrite-derived radicals by flavonoids may support endothelial NO synthase activity, contributing to the vascular protection associated with high fruit and vegetable intakes. Med Hypotheses. 2008;70: 170-181.
142. Mladenka P, Zatloukalova L, Filipsky T, et al. Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity. Free Radic Biol Med. 2010;49: 963-975.
143. Morel I, Lescoat G, Cogrel P, et al. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem Pharmacol. 1993;45:13-19.
144. Nijveldt RJ, van Nood E, van Hoorn DEC, et al. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr. 2001;74: 418-425.
145. Peri L, Pietraforte D, Scorza G, et al. Apples increase nitric oxide production by human saliva at the acidic pH of the stomach: a new biological function for polyphenols with a catechol group? Free Radic Biol Med. 2005;39: 668-681.
146. Schroeter H, Heiss C, Balzer J, et al. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A. 2006;103:1024-1029.
147. Stoclet JC, Chataigneau T, Ndiaye M, et al. Vascular protection by dietary polyphenols. Eur J Pharmacol. 2004;500:299-313.
148. Takahama U, Oniki T, Hirota S, et al. Oxidation of quercetin by salivary components. Quercetin-dependent reduction of salivary nitrite under acidic conditions producing nitric oxide. J Agric Food Chem. 2002;50:4317-4322.
149. Takahama U, Tanaka M, Hirota S. Proanthocyanidins in buckwheat flour can reduce salivary nitrite to nitric oxide in the stomach. Plant Foods Hum Nutr. 2010; 65:1-7.
150. Volk J, Gorelik S, Granit R, et al. The dual function of nitrite under stomach conditions is modulated by reducing compounds. Free Radic Biol Med. 2009;47: 496-502.
151. Hollman PCH, Cassidy A, Comte B, et al. The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J Nutr. 2011;141:989S-1009S.
152. Shen Y, Croft KD, Hodgson JM, et al. Quercetin and its metabolites improve vessel function by inducing eNOS activity via phosphorylation of AMPK. Biochem Pharmacol. 2012;84:1036-1044.
153. Shen Y, Ward NC, Hodgson JM, Puddey IB, Wang Y, Zhang D, Maghzal GJ, Stocker R, Croft KD. Dietary quercetin attenuates oxidant-induced endothelial dysfunction and atherosclerosis in apolipoprotein E knockout mice fed a high-fat diet: a critical role for heme oxygenase-1. Free Radical Biology and Medicine 2013;65:908-15.
154. Fisher NDL, Hughes M, Gerhard-Herman M, et al. Flavanol-rich cocoa induces nitric- oxide-dependent vasodilation in healthy humans. J Hypertens. 2003;21: 2281-2286.
155. Taubert D, Roesen R, Lehmann C, et al. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA. 2007;298:49-60.
156. Steffen Y, Gruber C, Schewe T, et al. Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem Biophys. 2008;469:209-219.
157. Anter E, Thomas SR, Schulz E, et al. Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols. J Biol Chem. 2004;279: 46637-46643.
158. Duffy SJ, Keaney JF Jr, Holbrook M, et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation. 2001;104:151-156.
159. Schnorr O, Brossette T, Momma TY, et al. Cocoa flavanols lower vascular arginase activity in human endothelial cells in vitro and in erythrocytes in vivo. Arch Biochem Biophys. 2008;476:211-215.
160. Skibola CF, Smith MT. Potential health impacts of excessive flavonoid intake. Free Radic Biol Med. 2000;29:375-383.
161. Egert S, Rimbach G. Which sources of flavonoids: complex diets or dietary supplements? Adv Nutr. 2011;2:8-14.
162. Mennen LI, Walker R, Bennetau-Pelissero C, et al. Risks and safety of polyphenol consumption. Am J Clin Nutr. 2005;81:326S-329S.
163. van Velzen AG, Sips AJAM, Schothorst RC, et al. The oral bioavailability of nitrate from nitrate-rich vegetables in humans. Toxicol Lett. 2008;181:177-181.
164. Jean ATP. Dietary exposure models for nitrates and nitrites. Food Control. 1998;9: 385-395.
165. Anjana US, Abrol YP. Are nitrate concentrations in leafy vegetables within safe limits? Curr Sci. 2007;92:355-360.
166. Pennington JAT. Dietary exposure models for nitrates and nitrites. Food Control. 1998;9:385-395.
167. Petersen A, Stoltze S. Nitrate and nitrite in vegetables on the Danish market: content and intake. Food Addit Contam. 1999;16:291-299.
168. Ysart G, Miller P, Barrett G, et al. Dietary exposures to nitrate in the UK. Food Addit Contam. 1999;16:521-532.
169. Santamaria P. Nitrate in vegetables: toxicity, content, intake and EC regulation. J Sci Food Agr. 2006;86:10-17.
170. Addiscott TM. Nitrate, Agriculture and the Environment. Oxford: CABI Publishing; 2005.
171. Gangolli SD, van den Brandt PA, Feron VJ, et al. Nitrate, nitrite and N-nitroso compounds. Eur J Pharmacol. (Environ Toxicol Pharmacol Sect.). 1994; 292:1-38.
172. Keys A. Mediterranean diet and public health: personal reflections. Am J Clin Nutr. 1995;61:1321S-1323S.
173. Sobko T, Marcus C, Govoni M, et al. Dietary nitrate in Japanese traditional foods lowers diastolic blood pressure in healthy volunteers. Nitric Oxide. 2010;22: 136-140.
174. Yamori Y, Miura A, Taira K. Implications from and for food cultures for cardiovascular diseases: Japanese food, particularly Okinawan diets. Asia Pac J Clin Nutr. 2001;10:144-145.
175. Hord NG, Tang Y, Bryan NS. Food sources of nitrates and nitrites: the physiologic context for potential health benefits. Am J Clin Nutr. 2009;90:1-10.
176. Lundberg JO, Feelisch M, Bjorne H, et al. Cardioprotective effects of vegetables: is nitrate the answer? Nitric Oxide. 2006;15:359-362.
177. Bryan NS, Hord NG. Dietary nitrates and nitrites: the physiological context for potential health benefits. In: NS Bryan, ed. Food, Nutrition and the Nitric Oxide Pathway: Biochemistry and Bioactivity. Lancaster PA: DESTech Publications Inc.; 2010.
178. Hung HC, Joshipura KJ, Jiang R, et al. Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst. 2004;96:1577-1584.
179. Lajous M, Willett W. Nutritional epidemiology of nitrogen oxides: what do the numbers mean? In: NS Bryan, J Loscalzo, eds. Nitrite and Nitrate in Human Health and Disease. Springer Science+Business Media, New York; 2011:85-96.
180. Benjamin N, O'Driscoll F, Dougall H, et al. Stomach NO synthesis. Nature. 1994; 368:502.
181. Lundberg JO, Weitzberg E, Lundberg JM, et al. Intragastric nitric oxide production in humans: measurements in expelled air. Gut. 1994;35:1543-1546.
182. Zweier JL, Wang P, Samouilov A, et al. Enzyme-independent formation of nitric oxide in biological tissues. Nat Med. 1995;1:804-809.
183. Bahra M, Kapil V, Pearl V, et al. Inorganic nitrate ingestion improves vascular compliance but does not alter flow-mediated dilatation in healthy volunteers. Nitric Oxide. 2012;26:197-202.
184. Bailey SJ, Fulford J, Vanhatalo A, et al. Dietary nitrate supplementation enhances muscle contractile efficiency during knee-extensor exercise in humans. J Appl Physiol. 2010;109:135-148.
185. Bailey SJ, Winyard P, Vanhatalo A, et al. Dietary nitrate supplementation reduces the O2 cost of low-intensity exercise and enhances tolerance to high-intensity exercise in humans. J Appl Physiol. 2009;107:1144-1155.
186. Cermak NM, Gibala MJ, van Loon LJ. Nitrate supplementation's improvement of 10-km time-trial performance in trained cyclists. Int J Sport Nutr Exerc Metab. 2012;22:64-71.
187. Coles LT, Clifton PM. Effect of beetroot juice on lowering blood pressure in freeliving, disease-free adults: a randomized, placebo-controlled trial. Nutrition J. 2012;11:106.
188. Gilchrist M, Winyard PG, Aizawa K, et al. Effect of dietary nitrate on blood pressure, endothelial function, and insulin sensitivity in type 2 diabetes. Free Radic Biol Med. 2013;60:89-97.
189. Hobbs DA, Kaffa N, George TW, et al. Blood pressure-lowering effects of beetroot juice and novel beetroot-enriched bread products in normotensive male subjects. Br J Nutr. 2012;1:1-9.
190. Kapil V, Milsom AB, Okorie M, et al. Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension. 2010;56:274-281.
191. Kelly J, Fulford J, Vanhatalo A, et al. Effects of short-term dietary nitrate supplementation on blood pressure, O2 uptake kinetics, and muscle and cognitive function in older adults. Am J Physiol Regul Integr Comp Physiol. 2013;304: R73-R83.
192. Kenjale AA, Ham KL, Stabler T, et al. Dietary nitrate supplementation enhances exercise performance in peripheral arterial disease. J Appl Physiol. 2011;110: 1582-1591.
193. Kukadia S, Tillin T, Coady E, et al. Dietary inorganic nitrate lowers central blood pressure. Artery Res. 2013;7:142.
194. Lansley KE, Winyard PG, Bailey SJ, et al. Acute dietary nitrate supplementation improves cycling time trial performance. Med Sci Sports Exerc. 2011;43: 1125-1131.
195. Lansley KE, Winyard PG, Fulford J, et al. Dietary nitrate supplementation reduces the O2 cost of walking and running: a placebo-controlled study. J Appl Physiol. 2011;110:591-600.
196. Larsen FJ, Weitzberg E, Lundberg JO, et al. Effects of dietary nitrate on oxygen cost during exercise. Acta Physiol. 2007;191:59-66.
197. Lidder S, Hunt J, Omar S, et al. P46. Acute effects of dietary nitrate on glucose handling and insulin levels during an oral glucose tolerance test in healthy subjects. Nitric Oxide. 2011;24:S32.
198. Liu AH, Bondonno CP, Croft KD, et al. Effects of a nitrate-rich meal on arterial stiffness and blood pressure in healthy volunteers. Nitric Oxide. 2013;35:123-130.
199. Rammos C, Hendgen-Cotta UB, Sobierajski J, et al. Dietary nitrate reverses vascular dysfunction in old adults with moderately increased cardiovascular risk. J Am Coll Cardio. 2013;63:1584-1585.
200. Vanhatalo A, Bailey SJ, Blackwell JR, et al. Acute and chronic effects of dietary nitrate supplementation on blood pressure and the physiological responses to moderate-intensity and incremental exercise. Am J Physiol Regul Integr Comp Physiol. 2010;299:R1121-R1131.
201. Siervo M, Lara J, Ogbonmwan I, et al. Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: a systematic review and metaanalysis. J Nutr. 2013;143:818-826.
202. Rammos C, Hendgen-Cotta UB, Sobierajski J, et al. Dietary nitrate reverses vascular dysfunction in old adults with moderately increased cardiovascular risk. J Am Coll Cardiol. 2013;63:1584-1585.
203. Kapil V, Haydar S, Pearl V, et al. Physiological role for nitrate-reducing oral bacteria in blood pressure control. Free Radic Biol Med. 2013;55:93-100.
204. Carlström M, Liu M, Yang T, et al. Cross-talk between nitrate-nitrite-NO and NO synthase pathways in control of vascular NO homeostasis. Antioxid Redox Sign. 2014;doi:10.1089/ars.2013.5481.
205. Heiss C, Meyer C, Totzeck M, et al. Dietary inorganic nitrate mobilizes circulating angiogenic cells. Free Radic Biol Med. 2012;52:1767-1772.
206. Joris PJ, Mensink RP. Beetroot juice improves in overweight and slightly obese men postprandial endothelial function after consumption of a mixed meal. Atherosclerosis. 2013;231:78-83.
207. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. The Lancet. 1997;349: 1498-1504.
208. Baker JE, Su J, Fu X, et al. Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and KATP channels. J Mol Cell Cardiol. 2007;43:437-444.
209. Duranski MR, Greer JJ, Dejam A, et al. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest. 2005;115: 1232-1240.
210. Jung KH, Chu K, Ko SY, et al. Early intravenous infusion of sodium nitrite protects brain against in vivo ischemia-reperfusion injury. Stroke. 2006;37:2744-2750.
211. Kumar D, Branch BG, Pattillo CB, et al. Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis. Proc Natl Acad Sci U S A. 2008;105:7540-7545.
212. Lu P, Liu F, Yao Z, et al. Nitrite-derived nitric oxide by xanthine oxidoreductase protects the liver against ischemia-reperfusion injury. Hepatobiliary Pancreat Dis Int. 2005;4:350-355.
213. Tripatara P, Patel NS, Webb A, et al. Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase. J Am Soc Nephrol. 2007;18:570-580.
214. Tannenbaum SR, Weisman M, Fett D. The effect of nitrate intake on nitrite formation in human saliva. Food Cosmet Toxicol. 1976;14:549-552.
215. Newberne PM. Nitrite promotes lymphoma incidence in rats. Science. 1979;204: 1079-1081.
216. Speijers G. P.A.v.d. Brandt. Nitrate. In: Food Additives Series. 2003. Joint FAO/ WHO Expert Committee on Food Additives, Geneva.
217. World Health Organization. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 2006, Vol. 94. International Agency for Research on Cancer, Lyon, France.
218. European Food Safety Authority. Nitrate in vegetables: scientific opinion of the Panel on Contaminants in the Food Chain. EFSA J. 2008;689:1-79.
219. Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus. Circulation. 2010;121:2271-2283.
220. Comly HH. Cyanosis in infants caused by nitrates in well water. JAMA. 1945;129: 112-116.
221. Avery AA. Infantile methemoglobinemia: reexamining the role of drinking water nitrates. Environ Health Perspect. 1999;107:583-586.
222. Cornblath M, Hartmann AF. Methemoglobinemia in young infants. J Pediatr. 1948;33:421-425.
223. Powlson DS, Addiscott TM, Benjamin N, et al. When does nitrate become a risk for humans? J Environ Qual. 2008;37:291-295.
224. Rocha BS, Gago B, Barbosa RM, et al. Dietary polyphenols generate nitric oxide from nitrite in the stomach and induce smooth muscle relaxation. Toxicology. 2009;265:41-48.
225. Rocha BS, Gago B, Barbosa RM, et al. Diffusion of nitric oxide through the gastric wall upon reduction of nitrite by red wine: physiological impact. Nitric Oxide. 2010;22:235-241.